...
首页> 外文期刊>Kidney and blood pressure research >Revised Equations to Estimate Glomerular Filtration Rate from Serum Creatinine and Cystatin C in China
【24h】

Revised Equations to Estimate Glomerular Filtration Rate from Serum Creatinine and Cystatin C in China

机译:中国血清肌酐和胱抑素C估算肾小球滤过率的修正公式

获取原文
           

摘要

Aim: Our previous study demonstrated that the cystatin C-based chronic kidney disease (CKD)-EPI equation and combined by serum creatinine (CKD-EPIscr-cys) had better capability to accurately evaluate glomerular filtration rate in the CKD participants. Considering that the accuracy of estimated glomerular filtration rate (eGFR) remains less ideally, it is essential to modify the equation by including the Chinese eGFR racial factor in order to improve its performance. Methods: Two prospective cohorts were enrolled in 2 medical centers. New equations were developed in 529 participants and validated in 313 participants. Reference glomerular filtration rate (rGFR) was taken by sup99m/supTc-DTPA renal dynamic imaging method (Gates method). The primary outcomes of this study were bias, precision (interquartile range of difference [IQR]), and accuracy (the proportion of eGFR within 30% of rGFR [P30] and root mean square error [RMSE]) of eGFR versus rGFR. Results: In a development data set, Chinese coefficients for CKD-EPIscr (C-CKD-EPIscr), CKD-EPIcys (C-CKD-EPIcys), and CKD-EPIscr-cys (C-CKD-EPIscr-cys) were 0.871, 0.879, and 0.891, respectively. In a validation data set, C-CKD-EPIcys was the most accurate with highest P30 value (62.3%), relative lowest IQR (15.45), and RMSE (0.80) among 6 equations, though the bias of C-CKD-EPIcys was not better than CKD-EPIcys. C-CKD-EPIscr and C-CKD-EPIscr-cys equations were improved in bias ( p 0.001), precision, and accuracy ( p = 0.004 and 0.001 for P30) compared with CKD-EPIscr and CKD-EPIscr-cys. Conclusion: C-CKD-EPIcys was the most accurate with the highest P30 value, relative lowest IQR, and RMSE among 6 equations. C-CKD-EPIscr and C-CKD-EPIscr-cys equations were improved in bias, precision, and accuracy. Other external validation of these equations is needed.
机译:目的:我们先前的研究表明,基于半胱氨​​酸蛋白酶抑制剂C的慢性肾脏病(CKD)-EPI方程与血清肌酐(CKD-EPIscr-cys)相结合,能够更好地评估CKD参与者的肾小球滤过率。考虑到估计的肾小球滤过率(eGFR)的准确性仍然不太理想,因此必须通过包括中国eGFR种族因素来修改方程,以提高其性能。方法:将两个预期队列纳入两个医疗中心。在529名参与者中开发了新的方程式,并在313名参与者中进行了验证。参考肾小球滤过率(rGFR)采用 99m Tc-DTPA肾动态显像法(盖茨法)。这项研究的主要结果是eGFR与rGFR的偏倚,准确性(差异的四分位数间距[IQR])和准确性(eGFR的比例在rGFR的30%以内[P30]和均方根误差[RMSE]以内)。结果:在开发数据集中,CKD-EPIscr(C-CKD-EPIscr),CKD-EPIcys(C-CKD-EPIcys)和CKD-EPIscr-cys(C-CKD-EPIscr-cys)的中文系数为0.871 ,分别为0.879和0.891。在一个验证数据集中,C-CKD-EPIcys最准确,P30值最高(62.3%),相对最低的IQR(15.45)和RMSE(0.80),尽管C-CKD-EPIcys的偏差为不比CKD-EPIcys好。与CKD-EPIscr和CKD-EPIscr-cys相比,C-CKD-EPIscr和C-CKD-EPIscr-cys方程的偏置(p <0.001),精度和准确性(p30的p = 0.004和<0.001)有所改善。结论:在六个方程中,C-CKD-EPIcys最准确,P30值最高,IQR相对最低,RMSE最低。 C-CKD-EPIscr和C-CKD-EPIscr-cys方程的偏置,精度和准确性均得到改善。这些方程式需要其他外部验证。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号